Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma. [electronic resource]
Producer: 20160912Description: e3259 p. digitalISSN:- 1536-5964
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab -- administration & dosage
- Cetuximab -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Nausea -- chemically induced
- Pancreatic Neoplasms -- drug therapy
- Retrospective Studies
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.